We don’t support this browser anymore.
This means our website may not look and work as you would expect. Read more about browsers and how to update them here.

Skip to main content
  • Register
  • Help
  • Contact us

MDxHEALTH SA (MDXH) NPV

Sell:€0.91 Buy:€0.94 Change: €0.002 (0.21%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Sell:€0.91
Buy:€0.94
Change: €0.002 (0.21%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
Sell:€0.91
Buy:€0.94
Change: €0.002 (0.21%)
Market closed |  Prices as at close on 3 December 2021 | Switch to live prices |
The selling price currently displayed is higher than the buying price. This can occur temporarily for a variety of reasons; shortly before the market opens, after the market closes or because of extraordinary price volatility during the trading day.

Business summary

MDxHealth SA is a Belgium-based healthcare company which provides actionable molecular diagnostic information to personalize the diagnosis and treatment of cancer. The Company’s tests are based on proprietary genetic, epigenetic (methylation) and other molecular technologies and assist physicians with the diagnosis of urologic cancers, prognosis of recurrence risk, as well as prediction of response to a specific therapy. Its tests include ConfirmMDx for Prostate Cancer, SelectMDx for Prostate Cancer, PredictMDx for Glioblastoma and AssureMDx for Bladder Cancer. The Company's corporate operations are based in Herstal, Belgium, as well as Irvine, the United States, and its laboratory operations are based in Nijmegen, the Netherlands, as well as Irvine, the United States.

Contact details

Address:
CAP Business Center, Rue d'Abhooz 31
HERSTAL
4040
Belgium
Telephone:
+32 (4) 2577021
Website:
https://mdxhealth.com/

Important dates

Future events
There are no future events available.
Past events
There are no past events available.

General stock information

Short code:
MDXH
ISIN:
BE0003844611
Market cap:
€110.65 million
Shares in issue:
118.47 million
Sector:
Biotechnology
Exchange:
Euronext Brussels
Country:
Belgium
Currency:
Euro
Indices:
n/a

Key personnel

  • Michael McGarrity
    Chief Executive Officer, Director
  • Ron Kalfus
    Chief Financial Officer
  • Joseph Sollee
    Executive Vice President, Chief Compliance Officer, General Counsel
  • Christopher Thibodeau
    Executive Vice President & U.S. Chief Operations Officer
  • John Bellano
    Chief Commercial Officer

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Business summary, contact details and key personnel provided by Thomson Reuters. Important dates provided by Digital Look Ltd. General stock information provided by Reuters.

Share

The London Stock Exchange does not disclose whether a trade is a buy or a sell so this data is estimated based on the trade price received and the LSE-quoted mid-price at the point the trade is placed. It should only be considered an indication and not a recommendation.

Trades priced above the mid-price at the time the trade is placed are labelled as a buy; those priced below the mid-price are sells; and those priced close to the mid-price or declared late are labelled 'N/A'.